Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01685229 · ClinicalTrials.gov registry record
Medical Therapy Versus Balloon Sinus Dilation for Patients With Chronic Rhinosinusitis
A clinical trial of Sinusitis, sponsored by Integra LifeSciences Corporation.
- Completed
- Registry status
- 198
- Enrollment target
- 20
- Study locations
NCT01685229 is a study of Sinusitis that has completed, run by Integra LifeSciences Corporation. The registered enrollment target is 198 participants, above the 114-participant average among 12 other Sinusitis trials with a reported enrollment target (74% higher). The trial reports 20 study locations across 11 states.
The verdict
NCT01685229, a study of Sinusitis, has completed, sponsored by Integra LifeSciences Corporation.
- COMPLETED
- Registry status
- 198 participants
- Enrollment target
- 20
- Study locations
Study Summary
This post-market study aims to compare health outcomes for Chronic Rhinosinusitis (CRS) patients treated with balloon sinus dilation (BSD) versus continued medical management.
Conditions Studied
Interventions
- DEVICE Balloon sinus dilation
- DRUG Medical Management
Study Locations (20)
Georgia
- - Atlanta
- - Savannah
- - Vidalia
Texas
- - Frisco
- - McKinney
- - Plano
Virginia
- - Charlottesville
- - Norfolk
- - Richmond
Florida
- - Miami
- - Tampa
Illinois
- - Chicago
- - Rockford
Wisconsin
- - Beaver Dam
- - Wauwatosa
Colorado
- - Denver
Indiana
- - South Bend
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 198 participants |
| Start Date | 2012-09-01 |
| Est. Completion | 2015-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01685229
The ClinicalTrials.gov registry entry for NCT01685229 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 198 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 114-participant average among 12 other Sinusitis trials with a reported enrollment target (74% higher). The listed sponsor is Integra LifeSciences Corporation, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sinusitis appearing as the primary indexed condition, and to 2 interventions - of which Balloon sinus dilation is the first listed.
NCT01685229 reports 20 study locations spanning 11 distinct geographic areas - top geographies include Georgia, Texas, Virginia.
Frequently Asked Questions
What is clinical trial NCT01685229 about?
NCT01685229 is a clinical study titled "Medical Therapy Versus Balloon Sinus Dilation for Patients With Chronic Rhinosinusitis". This post-market study aims to compare health outcomes for Chronic Rhinosinusitis (CRS) patients treated with balloon sinus dilation (BSD) versus continued medical management.
What is the current status of trial NCT01685229?
This trial is currently completed. The enrollment target is 198 participants. The study started on 2012-09-01. Estimated completion is 2015-08-01.
What conditions does trial NCT01685229 study?
This clinical trial studies the following conditions: Sinusitis.
What interventions are being tested in trial NCT01685229?
The interventions under investigation include: Balloon sinus dilation (DEVICE), Medical Management (DRUG).
Who is sponsoring clinical trial NCT01685229?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01685229 being conducted?
This trial has 20 study locations across Colorado, Florida, Georgia, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sinusitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.
RECRUITING · NA
-
High Resolution Micro OCT Imaging
ACTIVE NOT RECRUITING
-
Dupixent Study for Alternate Administration
ACTIVE NOT RECRUITING · Phase 4
-
Reducing Antibiotic Use by Implementation of Stewardship in Primary and Urgent Care
ACTIVE NOT RECRUITING
-
A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To
COMPLETED · Phase 2
-
Clinical Trial of the Treatment of Acute Sinusitis With Standard-dose Versus High-dose Amoxicillin/Clavulanate
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.